Information  X 
Enter a valid email address

ShieldTherapeutics Ord1.5P (STX)

Date Time Source Announcement
09 Nov 2018 3:46 pm
RNS
Holding(s) in Company
08 Nov 2018 6:21 pm
RNS
Holding(s) in Company
01 Oct 2018 1:54 pm
RNS
Notification Of Major Holdings
  7:00 am
RNS
Submission of an NDA for Feraccru? with the FDA
24 Sep 2018 1:06 pm
RNS
Director/PDMR Shareholding
  1:02 pm
RNS
Holding(s) in Company
19 Sep 2018 7:14 am
RNS
Licence for the commercialisation of Feraccru
  7:12 am
RNS
Interim Results
13 Sep 2018 7:00 am
RNS
AEGIS-H2H Completion of Recruitment
26 Jul 2018 7:00 am
RNS
Appointment of Non-Executive Director
23 Jul 2018 7:00 am
RNS
Business Update
09 Jul 2018 4:27 pm
RNS
Holdings in Company
  4:26 pm
RNS
Holdings in Company
28 Jun 2018 11:56 am
RNS
Result of AGM
  7:00 am
RNS
Data from real-world clinical use of Feraccru
14 Jun 2018 7:00 am
RNS
Positive top-line results from AEGIS-PAED PK study
05 Jun 2018 7:00 am
RNS
Directorate Change
  7:00 am
RNS
2017 Annual Report and 2018 AGM Notice
15 May 2018 6:21 pm
RNS
Grant of share options
04 May 2018 9:20 am
RNS
Holding(s) in Company
03 May 2018 5:26 pm
RNS
Holding(s) in Company
02 May 2018 11:00 am
RNS
Price Monitoring Extension
11 Apr 2018 7:00 am
RNS
Preliminary Results for the Year Ended 31 Dec 17
06 Apr 2018 7:00 am
RNS
Appointment of Non-Executive Director
  7:00 am
RNS
Results of Pre-Submission Meeting with FDA
27 Mar 2018 7:00 am
RNS
Broadening of Feraccru indication
16 Mar 2018 7:00 am
RNS
Update on the AEGIS-CKD study
23 Feb 2018 1:56 pm
RNS
Receives CHMP positive opinion on Feraccru?
22 Feb 2018 7:00 am
RNS
Business and Trading Update
05 Feb 2018 7:00 am
RNS
Top-line results from Feraccru Phase III study
29 Jan 2018 7:00 am
RNS
Notice of Results
25 Jan 2018 7:00 am
RNS
Grant of share options
10 Oct 2017 7:00 am
RNS
Completion of patient enrolment in Phase 3 study
05 Oct 2017 7:00 am
RNS
PDMR Acquisition of Shares
20 Sep 2017 7:00 am
RNS
Interim Report
14 Sep 2017 7:00 am
RNS
Board Change
06 Sep 2017 7:00 am
RNS
US Composition of Matter Patent Allowed
31 Aug 2017 7:00 am
RNS
Shield to Present at Baird Healthcare Conference
15 Aug 2017 7:00 am
RNS
Notice of Results
11 Jul 2017 2:59 pm
RNS
Grant of Share Options
10 Jul 2017 4:16 pm
RNS
Holding(s) in Company
  4:16 pm
RNS
Holding(s) in Company
06 Jul 2017 7:00 am
RNS
Feraccru licence agreement for Switzerland
05 Jul 2017 12:38 pm
RNS
Holding(s) in Company
03 Jul 2017 12:34 pm
RNS
Warrant Exercise and Expiry
28 Jun 2017 10:37 am
RNS
Holding(s) in Company
  8:00 am
RNS
Admission of New Ordinary Shares
22 Jun 2017 7:00 am
RNS
Biomarker data on ferric maltol in patients
15 Jun 2017 1:59 pm
RNS
Results of Fundraise
  7:00 am
RNS
Proposed Fundraise
13 Jun 2017 2:40 pm
RNS
Result of AGM
26 May 2017 7:00 am
RNS
Appointment of Joint Broker
28 Apr 2017 7:00 am
RNS
Annual Report, Accounts and AGM Notification
04 Apr 2017 7:00 am
RNS
Appointment of Chief Financial Officer
  7:00 am
RNS
Preliminary Results for the Year Ended 31 Dec 2016
13 Mar 2017 7:00 am
RNS
Notice of Results
  7:00 am
RNS
IP Portfolio Update
30 Jan 2017 10:50 am
RNS
Directorate and Secretarial Update
06 Jan 2017 7:00 am
RNS
Business Update
07 Nov 2016 7:00 am
RNS
Board Change
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t